Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cancer-Fighting Biotech OncoGenex Rates a Buy
Minyanville
Friday, March 16, 2012 - 11:40am
tags:
OncoGenex
Pfizer: Pipeline Story to Support Strong Performance in 2012
Motley Fool
Friday, March 16, 2012 - 11:38am
tags:
Pfizer
Anthera to cut almost half of its workforce
Reuters
Friday, March 16, 2012 - 11:38am
tags:
layoffs, Anthera
Bayer makes non-binding offer for Pfizer unit - paper
Reuters
Friday, March 16, 2012 - 11:35am
tags:
Bayer, Pfizer, animal health, M&A
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
Yahoo
Friday, March 16, 2012 - 11:27am
tags:
Sanofi, Pluromed, M&A
FDA Staff Questions Benefits of Glaxo, Merck Cancer Drugs
Bloomberg
Friday, March 16, 2012 - 11:22am
tags:
GSK, Merck, FDA, Ariad Pharmaceuticals, ridaforolimus, Votrient
Pfizer triples pay for new CEO Read
Yahoo/AP
Friday, March 16, 2012 - 11:21am
tags:
Pfizer, Pharma CEOs, executive pay, Ian Read
United Therapeutics sues Sandoz over hypertension drug
Reuters
Thursday, March 15, 2012 - 10:39am
tags:
Sandoz, generics, lawsuits, United Therapeutics, Remodulin, pulmonary hypertension
German Panel Saw Little to No Added Benefit for Pfizer’s Eliquis
Bloomberg
Thursday, March 15, 2012 - 10:35am
tags:
Pfizer, Germany, Eliquis, Bristol-Myers Squibb
Teva gets U.S. nod to market Lexapro generic
Reuters
Thursday, March 15, 2012 - 9:51am
tags:
Teva Pharmaceuticals, generics, Lexapro, Forest Labs, antidepressants
Agenus Still Gaining On GSK Agreement Expansion
Seeking Alpha
Thursday, March 15, 2012 - 9:49am
tags:
Agenus, GSK, QS-21
Shire Withdraws Bid For Fabry Drug In The US
Pharmalot
Thursday, March 15, 2012 - 9:43am
tags:
Replagal, Shire, Fabry's disease
Shire to buy U.S. biotech firm FerroKin for up to $325 million
Reuters
Thursday, March 15, 2012 - 9:41am
tags:
Shire, FerroKin, M&A
GSK sells Europe OTC brands to Omega, Alli delayed
Reuters
Thursday, March 15, 2012 - 9:24am
tags:
GSK, Omega, Alli, OTC, M&A
4 Biotech Stocks Undervalued By Levered Free Cash Flow
Seeking Alpha
Thursday, March 15, 2012 - 9:23am
tags:
Cambrex, China Biologic, Obagi Medical Products, PDL Biopharma
XOMA's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, March 15, 2012 - 9:21am
tags:
Xoma, earnings
[video]The Drama's Not Over at Dendreon
Motley Fool
Thursday, March 15, 2012 - 9:20am
tags:
Dendreon, prostate cancer, Provenge
Abbott begins patient enrollment in two Phase 3 studies of HUMIRA
Yahoo/Fly on the Wall
Thursday, March 15, 2012 - 9:18am
tags:
Abbott Laboratories, Humira, hidradenitis suppurativa
Pfizer's $200 Million Mistake
Motley Fool
Thursday, March 15, 2012 - 9:11am
tags:
Pfizer, Biocon, insulin, diabetes
Endocyte rockets 60% on EU update
Marketwatch
Thursday, March 15, 2012 - 9:10am
tags:
Endocyte, Europe, ovarian cancer, EC145, EC20

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.